Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2021
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2021.
Key Financial Metrics
This Form 8-K serves as a notification of the release of financial results and does not contain specific numerical data within the text provided. The filing states that the detailed results are contained in a press release furnished as Exhibit 99.1. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this document.
Material Changes
The filing does not provide specific comparative data or material changes versus prior periods. It references the attached press release (Exhibit 99.1) for the announcement of results for the periods ended September 30, 2021.
Guidance, Outlook, and Risks
The text of this 8-K does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. These items are expected to be detailed in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 9, 2021) for specific revenue, net loss, and cash position figures.
- Verify the company's liquidity status and cash burn rate as detailed in the full press release.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full announcement.
- Confirm the trading symbol (ACHV) and exchange (NASDAQ Capital Market) for current market data.